Hospital

The forthcoming strategic plan will be focused on guiding future NIH research efforts to improve the health of all women throughout the life course.

For patients suffering from a higher left ventricular ejection fraction, a sodium-glucose cotransporter 2 inhibitor could decrease risk of hospitalization or death from heart failure.

Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.

Combination treatment with ibrutinib found to increase median progression-free survival by 2.3 years compared to the placebo.

There were approximately 250,000 new cases of prostate cancer identified in the United States in 2021, which is considered approximately 13% of all cancer cases.

Study finds that 13% of all heart-related emergency department visits were related to essential hypertension.

Investigators combine research discovery with technological development to determine whether the role of genomics in nephrology should remain with subspecialists or be integrated into general nephrology.

Gadopiclenol is a macrocyclic gadolinium-based contrast indicated for use in adults and children 2 years of age and older for contrast-enhanced MRI.

Patients could have a better immune response against the omicron variant of COVID-19 with a second booster of the bivalent mRNA-1273.214 vaccine at a 50 μg dose.

Included in the literature review were the known neurologic complications of smallpox, including encephalitis, transverse myelitis, and acute disseminated encephalomyelitis.

Experts discuss insight from a recently published oncology drug shortages research project and HOPA’s plan to address related issues based on the project’s findings.

Research suggests that an HIV patient’s risk of heart attack increases with each passing decade, and this risk is nearly 3-fold among patients with HIV who are also positive for hepatitis C.

Pfizer and BioNTech have also initiated a phase 1/2/3 study evaluating the safety, tolerability, and immunogenicity of different doses and dosing regimens with the vaccine in children.

Expert explains how delaying BCOP certification too long after a PGY2 residency can cause a “if you don’t use it, you’ll lose it” problem.

Certain states are proposing that out-of-state telemedicine care should be more accessible, which researchers believe is a trend that will continue.

A new cell isolation kit was approved by the FDA to decrease the amount of time needed in a lab and lower overall costs for testing tuberculosis.

The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.

Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.

Specialty pharmacies need processes, systems and tools to quickly determine medication delivery status, reassure confidence, and alleviate patient anxiety.

Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.

The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.

In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.

Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.

Program will start to distribute a free HIV self-test to people who enroll by early 2023.

Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.

Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.

The FDA accepted a supplemental New Drug Application for tucatinib to treat HER2 colorectal cancer, which could significantly improve outcomes for these patients.

The All of Us Research Program looks to enroll more than 1 million US individuals in the next 10 years to enable public access to medical data for research purposes.

Selpercatinib produced clinically meaningful and durable responses across a variety of tumor types in patients with RET-driven cancers.